North Growth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.27M | Hold |
34,000
| – | – | 0.8% | 42 |
|
2025
Q1 | $4.65M | Buy |
34,000
+16,000
| +89% | +$2.19M | 0.98% | 40 |
|
2024
Q4 | $2.73M | Buy |
18,000
+7,000
| +64% | +$1.06M | 0.52% | 41 |
|
2024
Q3 | $2.21M | Hold |
11,000
| – | – | 0.41% | 43 |
|
2024
Q2 | $2.63M | Hold |
11,000
| – | – | 0.52% | 41 |
|
2024
Q1 | $2.44M | Hold |
11,000
| – | – | 0.47% | 43 |
|
2023
Q4 | $2.95M | Hold |
11,000
| – | – | 0.63% | 42 |
|
2023
Q3 | $2.93M | Sell |
11,000
-1,000
| -8% | -$267K | 0.65% | 43 |
|
2023
Q2 | $3.32M | Hold |
12,000
| – | – | 0.68% | 42 |
|
2023
Q1 | $3.24M | Hold |
12,000
| – | – | 0.69% | 42 |
|
2022
Q4 | $3.28M | Hold |
12,000
| – | – | 0.75% | 41 |
|
2022
Q3 | $3.17M | Hold |
12,000
| – | – | 0.79% | 42 |
|
2022
Q2 | $2.42M | Hold |
12,000
| – | – | 0.56% | 43 |
|
2022
Q1 | $2.6M | Sell |
12,000
-16,000
| -57% | -$3.46M | 0.48% | 47 |
|
2021
Q4 | $6.61M | Sell |
28,000
-6,000
| -18% | -$1.42M | 1.1% | 38 |
|
2021
Q3 | $9.5M | Hold |
34,000
| – | – | 1.67% | 32 |
|
2021
Q2 | $11.6M | Hold |
34,000
| – | – | 1.89% | 23 |
|
2021
Q1 | $9.59M | Hold |
34,000
| – | – | 1.7% | 28 |
|
2020
Q4 | $8.4M | Buy |
34,000
+2,000
| +6% | +$494K | 1.72% | 31 |
|
2020
Q3 | $9M | Buy |
+32,000
| New | +$9M | 1.98% | 26 |
|